The global immuno-oncology assays market is estimated to be valued at US$ 3,718.5 million in 2021 and is expected to exhibit a CAGR of 10.7% over the forecast period 2022-2028, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Immuno-oncology assays are vital tools used in cancer research and treatment. These assays help in screening and monitoring cancer patients, as they provide valuable insights into the immune response to tumors. ... Read more
The global immuno-oncology assays market is estimated to be valued at US$3,718.5 Mn in 2021 and is expected to exhibit a CAGR of 10.7% over the forecast period 2022-2028.
A) Market Overview:
The immuno-oncology assays market is witnessing significant growth due to the increasing research and development in cancer immunotherapy. Immuno-oncology assays play a crucial role in understanding the interaction between the immune system and cancer cells, which helps in ... Read more
Immuno-oncology assays help in monitoring the levels of cancer biomarkers and T-cell activation markers in cancer patients undergoing immunotherapy treatment. These assays play a vital role in personalized cancer care by helping physicians optimize drug dosing, identify non-responders early, and monitor treatment response and disease progression. The global immuno-oncology assays market provides assays to monitor biomarkers such as PD-L1, IDO1, TIM-3, LAG-3, CTLA-4, and various cytokines ... Read more
Immuno-oncology assays are diagnostic tools used for research and drug development in cancer immunotherapy. These assays help monitor immune response by measuring PD-L1/PD-1 biomarkers and tumor-infiltrating lymphocytes. With the rising prevalence of cancer worldwide and advancements in immunotherapy, the need for personalized cancer treatment is growing. Immuno-oncology assays aid in understanding disease pathology at a molecular level to develop targeted therapies.
Immuno-oncology assays are laboratory tests that are used to detect and diagnose cancer using the body’s own immune system. They monitor the levels of immune cells and biomarkers in a patient’s blood or tumour tissue that play a role in the development or progression of cancer. Immuno-oncology assays help doctors evaluate a patient’s prognosis and select the most appropriate therapy. The global immuno-oncology assays market is primarily driven by the increasing prevalence of cancer worldwide ... Read more
